AKAP8L antibody (C-Term)
Quick Overview for AKAP8L antibody (C-Term) (ABIN1449809)
Target
See all AKAP8L AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Sequence
- APGAVSPPPP PPPEEEEEGA VPLLGGALQR QIRGIPGLDV EDDEEGGGGA
-
Cross-Reactivity (Details)
- Species reactivity (expected):Rat, Mouse, Dog, Rabbit, PigSpecies reactivity (tested):Human
-
Purification
- Purified using Protein A affinity column
-
Immunogen
- Synthetic peptide directed towards the C terminal of human AKAP8L
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Add 100 μL of distilled water to a final concentration of 1 mg/mL.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- AKAP8L (A Kinase (PRKA) Anchor Protein 8-Like (AKAP8L))
-
Alternative Name
- AKAP8L
-
Background
- AKAP8L could play a role in constitutive transport element (CTE)-mediated gene expression. It does not seem to be implicated in the binding of regulatory subunit II of PKA. It may be involved in nuclear envelope breakdown and chromatin condensation. It may regulate the initiation phase of DNA replication when associated with TMPO-beta.Synonyms: A-kinase anchor protein 8-like, AKAP8-like protein, HRIHFB2018, Helicase A-binding protein 95, Homologous to AKAP95 protein, NAKAP95, Neighbor of A-kinase-anchoring protein 95
-
Gene ID
- 26993
-
NCBI Accession
- NP_055186
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-